Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii
نویسندگان
چکیده
منابع مشابه
Metabolic Engineering of Probiotic Saccharomyces boulardii.
Saccharomyces boulardiiis a probiotic yeast that has been used for promoting gut health as well as preventing diarrheal diseases. This yeast not only exhibits beneficial phenotypes for gut health but also can stay longer in the gut than Saccharomyces cerevisiae Therefore, S. boulardiiis an attractive host for metabolic engineering to produce biomolecules of interest in the gut. However, the lac...
متن کاملSaccharomyces Boulardii - a Probiotic of Choice
The term ―probiotic‖ was first used in 1965 by Lilly and Stillwell, to describe substances secreted by one organism which stimulate the growth of another probiotics as ―live micro-organisms‖, which, when administered in adequate amounts confer a health benefit on the host .The use of probiotics for the prevention of antibiotic associated diarrhea (AAD) and the treatment of Clostridium difficile...
متن کاملSaccharomyces cerevisiae var. boulardii – Probiotic Yeast
The discovery and study of the budding yeast Saccharomyces cerevisiae var. boulardii (Sb) is strictly related to the concept of health promoting microorganisms from food. The first most well-known and popularized throughout Europe assumption of health promoting food containing living microorganisms was yogurt. Appointed in 1888 by Louis Pasteur, Ilya Ilyich Metchnikov working in Paris developed...
متن کاملEfficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.
Several clinical trials and experimental studies strongly suggest a place for Saccharomyces boulardii as a biotherapeutic agent for the prevention and treatment of several gastrointestinal diseases. S. boulardii mediates responses resembling the protective effects of the normal healthy gut flora. The multiple mechanisms of action of S. boulardii and its properties may explain its efficacy and b...
متن کاملSaccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile. We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed Saccharomyces cerevisiae var. boulardii fungemia in a central venous catheter during treatment of antibiotic-associated pseudomembranous colitis with the probiotic Saccha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Meditsinskiy sovet = Medical Council
سال: 2020
ISSN: 2658-5790,2079-701X
DOI: 10.21518/2079-701x-2020-5-104-112